日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical outcomes of monoclonal antibody therapy during a COVID-19 outbreak in a skilled nursing facility-Arizona, 2021

2021年亚利桑那州一家专业护理机构爆发COVID-19疫情期间单克隆抗体疗法的临床结果

Dale, Ariella P; Hudson, Matthew J; Armenta, Darunee; Friebus, Heather; Ellingson, Katherine D; Davis, Kat; Cullen, Theresa; Brady, Shane; Komatsu, Kenneth K; Stone, Nimalie D; Uyeki, Timothy M; Slifka, Kara Jacobs; Pérez-Vélez, Carlos M; Keaton, Amelia A

Administration of Bamlanivimab to Skilled Nursing Facility Residents During a COVID-19 Outbreak, January-February 2021, Arizona

2021年1月至2月,亚利桑那州,COVID-19疫情爆发期间,对专业护理机构居民使用Bamlanivimab进行治疗

Dale, Ariella P; Hudson, Matthew J; Cullen, Theresa; Ellingson, Katherine D; Davis, Kat; Armenta, Darunee; Friebus, Heather; Currie, Chase; Bhattarai, Rachana; Brady, Shane; Komatsu, Ken; Stone, Nimalie D; Uyeki, Timothy M; Slifka, Kara Jacobs; Perez-Velez, Carlos; Keaton, Amelia A

A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies.

PI-88 和多西他赛治疗晚期恶性肿瘤患者的 I 期药理学和生物学研究

Chow Laura Q M, Gustafson Daniel L, O'Bryant Cindy L, Gore Lia, Basche Michele, Holden Scott N, Morrow Mark C, Grolnic Stacy, Creese Brian R, Roberts Kaye L, Davis Kat, Addison Russell, Eckhardt S Gail